Real-World Outcomes of Patients With NSCLC Treated With PD-1 Inhibitors After Approval
Certain subgroups of patients with NSCLC are underrepresented in clinical trials for newly approved PD-1 inhibitors and are needed to inform real-world treatment decisions.
Multiple Myeloma, Lymphoma Respond Differently to Treatment for Anemia
A comparative effectiveness study analyzed response to anemia supportive treatment for patients with multiple myeloma or lymphoma.
Health Care Utilization High for Hospitalized Patients With Advanced Cancer
Clinical Pathways for Myeloid Growth Factors Lead to Appropriate Use
A poster presentation at AMCP Nexus 2017 found that the implementation of a clinical pathway increased the appropriate use of myeloid growth factors for patients receiving myelosuppressive cancer chemotherapy.